Skip to main content
TipRanks
Go Ultimate75% OFF

Varex Imaging (VI4) Q2 2026 Earnings Report

0 Followers

DE:VI4 Q2 2026 EPS Results

Actual EPS
EUR 0.19
Consensus EPS
EUR 0.19
Beat/Miss
Met expectations
One Year Ago EPS
EUR 0.24

DE:VI4 Q2 2026 Revenue Results

Actual Revenue
EUR 195.25M
Expected Revenue
EUR 196.08M
Beat/Miss
Missed by -EUR 828.90K
YoY Revenue Growth
+1.46%

Earnings Announcement Details

Quarter
Q2 2026
Date
05/07/2026
Time
After Close
Conference Call
Thursday, May 7, 2026
DE:VI4 Upcoming Earnings

Varex Imaging's next earnings date is estimated for November 24, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:VI4 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:May 07, 2026|% Change Since:61.76%|
Earnings Call Sentiment|Neutral

The call highlighted solid execution on guidance, margin resilience (non‑GAAP gross margin at the high end), successful debt refinancing and clear technology and industrial pipeline momentum (CT, photon-counting, cargo systems). Offsetting these positives are modest top‑line growth (+1% YoY), a GAAP loss, margin erosion versus the prior year (down ~240 bps), elevated inventory and short‑term working capital pressures. Management provided multi-quarter visibility (annual guidance) and actions (India ramp, pricing/contract renewal levers) that could improve margins over time, but near-term growth and margin recovery remain modest.

Company Guidance

Varex guided that second‑half fiscal 2026 revenue should be up roughly 3% year‑over‑year (guidance excludes any IEEPA tariff refund) and reiterated full‑year fiscal 2026 revenues of $860–$880 million with non‑GAAP EPS of $0.80–$1.00; Q3 guidance is $210–$225 million of revenue and non‑GAAP diluted EPS of $0.15–$0.30, based on non‑GAAP gross margin of 33–34%, non‑GAAP operating expenses of about $54 million, net interest and other expense of $6–$7 million, a Q3 tax rate of ~23% (full‑year tax expectation ~20%), and roughly 42 million diluted non‑GAAP shares outstanding, and management said it will resume providing annual guidance going forward.

  • Revenue Within Guidance and Continued DemandQ2 revenue of $216 million came in within guidance; total revenue increased 1% year-over-year, driven by medical (+2%) and industrial (+1%). Medical represented $156M (72% of total) and Industrial $60M (28%).
  • Strong Non-GAAP Margin and EPS ExecutionNon-GAAP gross margin was 34% (at the high end of guidance) and non-GAAP EPS was $0.21, in-line with expectations.
  • Improved Capital Structure via Debt RefinancingCompleted debt refinancing in the quarter, reducing outstanding debt and annual interest expense; gross debt $351M, cash & marketable securities $88M, net debt ~$263M — supporting greater financial flexibility.
  • Profitability Metrics and LeverageAdjusted EBITDA was $27M (12% of sales) for the quarter; trailing 12‑month adjusted EBITDA was $118M and net debt leverage was ~2.2x adjusted EBITDA.
  • Medical Product Momentum — CT and Photon CountingCT and radiography exceeded the company’s 5-quarter sales trend; CT remains a key growth driver. Photon-counting technology sales momentum remained strong with active engagement: 2 CT OEMs plus discussions with 8 additional OEMs across modalities.
  • Industrial Segment Traction and PipelineIndustrial saw continued demand for tubes, linear accelerators, detectors and cargo security systems; company reported multiple new cargo inspection deals (including mobile systems and car scanners) and expects industrial to be an increasing driver of growth and margin expansion.
  • Regional Strength in Americas and APACAmericas grew 13% YoY and APAC grew 8% YoY, providing geographic pockets of strong demand.
  • Manufacturing Ramp in India Expected to Improve MarginsDetector factory in India completed and ramping (utilization currently low but expected to be materially utilized by year-end); company expects this to convert current gross margin and OpEx headwinds into tailwinds as utilization rises toward ~60–70%.
  • Forward Guidance and Return to Annual Guidance PracticeCompany provided FY26 revenue guidance of $860M–$880M (second half revenue expected to be ~+3% YoY) and non-GAAP EPS guidance of $0.80–$1.00; management resumed providing an annual view citing improved visibility.

DE:VI4 Earnings History

DE:VI4 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 24, 20262026 (Q4)0.26-0.33――
Aug 10, 20262026 (Q3)0.190.280.1672.22% (+0.12)
May 07, 20262026 (Q2)0.190.190.24-19.23% (-0.05)
Feb 10, 20262026 (Q1)0.120.170.06171.43% (+0.11)
Nov 18, 20252025 (Q4)0.170.330.1794.74% (+0.16)
Aug 07, 20252025 (Q3)0.030.160.1328.57% (+0.04)
May 08, 20252025 (Q2)0.130.240.1462.50% (+0.09)
Feb 06, 20252025 (Q1)0.020.060.0516.67% (+0.01)
Nov 19, 20242024 (Q4)0.080.170.41-57.78% (-0.24)
Aug 01, 20242024 (Q3)0.140.130.33-62.16% (-0.21)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed